Blogs about: Fdaaa
Featured Blog
REMS and Generics -- Like Oil and Water
A great post from Michael McCaughan at the In Vivo Blog walks through the very complicated interaction between the world of REMS — the FDA’s Risk Evaluation and Mitigation Strategies that … more →
The Cross-Border Biotech Blog
REMS and Generics -- Like Oil and Water
Jeremy G wrote 3 weeks ago: A great post from Michael McCaughan at the In Vivo Blog walks through the very complicated interacti … more →
Disclosure, Disclosure, Disclosure
Jeremy G wrote 3 months ago: Disclosure issues have permeated the news lately. Pharmaceutical companies need to do a better job … more →
US FDA approvals in 2008 totaled 21 new molecular entities (NMEs)
tristar3research wrote 5 months ago: Specialty products continued to dominate new drug and biologic approvals in the US in a year in whic … more →
Risk Evaluation and Mitigation Strategy (REMS) for Certain Drugs and Biologics
— 2 comments
abhishekkatiyar wrote 10 months ago: The U.S. Food and Drug Administration has identified 25 drugs and biologic products that will be req … more →
What you should know about FDAAA 2007!
KHOI wrote 1 year ago: On September 27, 2007, President Bush signed the Food and Drug Administration Amendment Act of 2007 … more →
Have your say. Start a blog.
See our free features →
An 
Opus
